>It seems like a great story. Unfortunately, all my story stocks have seemed like great stories! And not all have been. <
Right. Something like 8 or 9 out of 10 new products fail! Yes, that is correct – easily verifiable by a lit search. But, for large companies, the failed products do not really show – due to the many already established products! I think the proper response, re small companies, to this dismal success rate is to be very diligent: dig deep and keep in mind that very large gains can come from being right about new products from small companies.
Obviously, I believe BSD Medical will continue to survive. Why not? – they have for decades! And, their products have not only survived but are recognized as world-leading in a very important, new cancer therapy modality (a new regime, not just a single product for a single tumor-type). Further, they now have at least one important product that is having very rapid sales growth (see my next post, though) – into a very substantial market. BSD Medical deserves close attention and careful analysis and patience (hence my restriction to long-term investors).
>OTOH, on the BSDM board you have the shorts chortling like a pack of hyeanas after a double wildebeest feast. “<
LOL Yes – and, I assume you mean that miserable Y! MB – what a cesspool!
>My guess as in investor is that the stock's bump will be subject to a reversion down for the time being. “
I would not be surprised. But, I expect many exciting news releases to further stimulate buying spurts. And, I expect the stock to rise accordingly – along some erratic path (daytrading mish-mash will see to that). < |